The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Open accessAbstract
Aberrant hepatocyte Notch activation is required for development of NASH-associated fibrosis, and Notch inhibition ameliorates obesity-induced liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In parallel, cholesterol and other mediators contribute to changes in the transcriptional programmes in steatotic hepatocytes, leading to an upregulation of developmental pathways that are often seen in bipotential progenitor cells or ductular cells, such as Notch and TAZ, which can directly activate pro-fibrotic cell-cell communication between hepatocytes and neighbouring cells.[28], [29], [30]”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [29]
In the citing paper
“osteopontin, which is induced by Notch and TAZ signalling129”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [129]
In the citing paper
“Blocking notch signaling in MASH, both genetically and pharmacologically, can attenuate MASH-associated liver fibrosis (114).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [114]
In the citing paper
“Notch signaling has been identified as an important driver of HSC activation in fibrosis in general (114, 153).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [114]
In the citing paper
“In hepatocytes, activation of TLR4 increases the expression of jagged 1 (JAG1), a well-established notch receptor 1 (NOTCH1) ligand, which leads to SRY-box transcription factor 9 (SOX9)-dependent transcription and secretion of SPP1, stimulating HSC activation (114).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Prevalence of Obesity Among Adults and Youth: United States, 2015-2016.
Hales, C. M., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2017) · PubMed · Cited by 3,889
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Self-citationAngulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Nonalcoholic Fatty Liver Disease
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,320
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–251 of 251
Multifaceted Human Antigen R (HuR): A Key Player in Liver Metabolism and MASLD
Eppler, N., Jones, E., Ahamed, F., & Zhang, Y. (2025) · Livers · doi:10.3390/livers5030033 · Cited by 3
Notch signaling in metabolic diseases: A key regulator and potential target
Xi, Z., Zhang, J., & Bao, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152492 · Cited by 3
Hepatocyte PLAGL2 deficiency alleviates MASH through MYD88-licensed inactivation of inflammasome
Duan, R., Wang, X., Wang, Q., Zhou, X., Gao, S., Sun, Y., Feng, Q., Li, Z., Yang, Z., Ding, J., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.116942 · Cited by 3
Self-citationLi, X., Jin, K., Fang, J., Ma, X., He, J., Lu, A., Jia, Z., & Shi, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835197 · Cited by 4
Progress of ADAM17 in Fibrosis‐Related Diseases
Yan, S., Zhao, Y., Yang, Y., Liu, B., Xu, W., Ma, Z., & Yang, Q. (2025) · Mediators of Inflammation · doi:10.1155/mi/9999723 · Cited by 4
Sun, J., Shi, R., Zhou, Z., Xu, W., Huai, J., Cao, Y., Zhang, W., Nie, L., Wang, G., Yan, Q., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142315 · Cited by 3
Self-citationYin, X., Liu, M., Xu, Y., Zhong, H., Zhang, J., Xie, H., Xiang, Y., Wan, J., & Chen, D. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.10.275 · Cited by 3
Plastic hepatocyte states limit liver cancer development
Strathearn, L. S., Hayata, Y., Illendula, A., Hewett, C. K., Chen, M., He, G.-S., Escribano-Cebrián, M., Jarboe, B., Gómez-Tomé, L., de Prisco, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66568-0 · Cited by 2
Lee, J. H., Song, H., Yoo, E. J., Jeong, Y., Ko, S. H. N. S. T., Shin, G. W., Choi, G. E., Jee, Y., Kang, M., Yang, J., et al. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02978-3 · Cited by 3
Notch signaling in liver diseases: mechanistic insights and therapeutic implications
Shi, Q., Lou, N., Huang, D., & Fu, L. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1770031 · Cited by 2
Zeng, C., Lu, Q., Zhao, Q., & Li, J. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08312-w · Cited by 3
NOTCH SIGNALING IN CONTEXT: BASIC AND TRANSLATIONAL IMPLICATIONS.
Aster, J. C. (2020) · PubMed Central · Cited by 2
Albhaisi, S. A. M., & Sanyal, A. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00121-3 · Cited by 2
CANALIS, E. M., Yu, J., Schilling, L., Jafar‐Nejad, P., & Carrer, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316644 · Cited by 2
Jiang, H.-T., Ye, H.-M., Yu, H.-Y., Zhu, Y., Hu, M., He, M., Li, W., Yu, Z., Yang, Q., He, L., et al. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x328447241023063825 · Cited by 1
Zhang, J., Zhao, Y., Pulivendala, G., Zhang, Q., Rui, L., Gao, J., Wang, H., Zhang, G., Nuotio-Antar, A. M., Tong, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202415032 · Cited by 1
Kei, N., Cheung, K. K., Lee, K., Yau, T. K., Lauw, S., Kang, X., Sun, K. W. Y., Wang, Y., Wong, V. W., Wong, S. H., et al. (2025) · Nutrients · doi:10.3390/nu17132245 · Cited by 1
Gc inhibition preserves insulin sensitivity and reduces body weight without loss of muscle mass
Gill, R., & Kuo, T. (2025) · JCI Insight · doi:10.1172/jci.insight.195341 · Cited by 2
Kim, A., Alligood, D. M., Maram, L., Phelps, H. M., Cameron, M. D., DeRousse, J. T., Han, J., Dunning, T. J., Mintz, R. L., Park, A. J., et al. (2026) · Gastroenterology · doi:10.1053/j.gastro.2025.12.015 · Cited by 1
Xu, S., Huang, J.-Y., Wang, K., Xiang, Y., Ma, N., Wang, Y., Zhang, F.-K., Chen, Y., Song, C., Ni, Q., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-5082 · Cited by 1
Self-citationCANALIS, E. M., Mocarska, M., Schilling, L., Jafar‐Nejad, P., & Carrer, M. (2023) · Bone · doi:10.1016/j.bone.2023.116898 · Cited by 1
Shaping Tomorrow's Liver Organoids: A Journey Toward Integrating Bile Ducts
Rizwan, M. (2023) · Advanced Biology · doi:10.1002/adbi.202300450 · Cited by 1
From fatty liver to nonalcoholic steatohepatitis with fibrosis
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00013-5 · Cited by 1
A novel role of RNase L in the development of nonalcoholic steatohepatitis
Chen, G., Zhao, X., Dankovskyy, M., Ansah-Zame, A., Alghamdi, U. M., Liu, D., Wei, R., Zhao, J., & Zhou, A. (2023) · The FASEB Journal · doi:10.1096/fj.202300621r · Cited by 1
Systemic benefits of Gc inhibition to preserve insulin sensitivityPreprint
Kuo, T., & Accili, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.06.328963 · Cited by 1
Notch signaling maintains a progenitor-like subclass of hepatocellular carcinomaPreprint
Seidel, K., Piskol, R., Nguyen, T. T. T., Shelton, A., Cottonham, C., de la Cruz, C. C., Castillo, J., Garcia, J., Segal, U., Merchant, M. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.13.628320 · Cited by 1
Hepatocyte CREBZF-osteopontin axis controls fibrosis in nonalcoholic steatohepatitisPreprint
Ma, F., Liu, Y., Hu, Z., Xue, Y., Liu, Z., Cai, G., Su, W., Zheng, Z., Ding, D., Sun, X., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-929976/v1
Abuja, P. M., Zatloukal, K., & Denk, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212545
Chen, C. S., & Drain, A. P. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735983425.793583678
Faculty Opinions recommendation of Senolytic CAR T cells reverse senescence-associated pathologies.
Pawelec, G. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738152729.793576459
Mechanisms of ductular reaction in non-alcoholic steatohepatitis
Chen, Y., Gao, W.-K., Shu, Y.-Y., & Ye, J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i19.0000 · Cited by 29
Mašek, J., Filipovic, I., Hul, N. V., Belicová, L., Jiroušková, M., Oliveira, D. V., Frontino, A. M., Hankeová, S., He, J., Turetti, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.24.513578
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Yu, J., & Pajvani, U. B. (2022) · Medical Review · doi:10.1515/mr-2022-0043
Self-citationThe role of reck in the pathogenesis of nonalcoholic steatohepatitis
Dashek, R. J. (2022) · doi:10.32469/10355/94274
Data from Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity
Chen, H.-A., Ho, Y.-J., Mezzadra, R., Adrover, J. M., Smolkin, R. M., Zhu, C., Woess, K., Bernstein, N., Schmitt, G., Fong, L. E., et al. (2023) · doi:10.1158/2159-8290.c.6549996.v1
Self-citationExperimental models of biliatresone-induced biliary atresiaPreprint
Serrano, G. L. G. (2023) · doi:10.31219/osf.io/9ac8q
Sjøgaard-Frich, L. M., Egeskov, C. M., Halling, J. F., Ponniah, M., Dmytriyeva, O., Pilegaard, H., & Pedersen, S. F. (2024) · Liver international communications. · doi:10.1002/lci2.70003
Šisl, D., Planinić, P., Novak, S., Filipović, M., Flegar, D., Šućur, A., Turčić, P., Kovačić, N., Kalajzić, I., Grčević, D., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1440236
Notch signaling maintains a progenitor-like subclass of hepatocellular carcinomaPreprint
Seidel, K., Piskol, R., Nguyen, T. T. T., Shelton, A., Cottonham, C., de la Cruz, C. C., Castillo, J., Garcia, J., Segal, U., Merchant, M. A., et al. (2025) · eLife · doi:10.7554/elife.105404
Notch signaling maintains a progenitor-like subclass of hepatocellular carcinomaPreprint
Seidel, K., Piskol, R., Nguyen, T. T. T., Shelton, A., Cottonham, C., de la Cruz, C. C., Castillo, J., Garcia, J., Segal, U., Merchant, M. A., et al. (2025) · eLife · doi:10.7554/elife.105404.1
Gaspar, R. C., Macêdo, A. P. A., Nakandakari, S. C. B. R., Muñoz, V. R., Abud, G. F., Vieira, R. F. L., Neto, I. V. D. S., Pavan, I. C. B., da Silva, L. G. S., Simabuco, F. M., et al. (2025) · Liver International · doi:10.1111/liv.70068 · Cited by 1
Self-citationKozlovich, S. Y., Pan, A. Y., McIntosh, J. J., Palatnik, A., Jia, S., Hessner, M. J., & Nghiem‐Rao, T. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-10808-2
Condorelli, A. G., El Hachem, M., Zambruno, G., Nyström, A., Candi, E., & Castiglia, D. (2021) · Figshare · doi:10.6084/m9.figshare.14562729
Chen, H., Yang, M., Tu, X., Li, J., Li, C., & Xia, J. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2026.03.001
Jiao, M., Sun, Y. X., Liu, R., Yin, X., Hou, X., Yuan, H., Dai, Z., Chen, Q., & Zhu, C. (2026) · Communications Biology · doi:10.1038/s42003-026-10476-6
Self-citationDysfunctional macrophages along the gut-liver axis: a driver of infection in cirrhosis
Aslan, D., Korf, H., Dumarey, A., Smets, L., Ghallab, A., Hengstler, J. G., Marques, P. E., & der Merwe, V. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1870116
Tacke, F., Detjen, K. M., Heisig, J., & Hampe, J. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2890-7253
Mechanotransduction Pathways in Liver Fibrosis: a Comprehensive Narrative Review
Jehangir, M., kashmiri, K., Tayyab, M., Kakhramonov, R., & Alvi, A. D. (2026) · Letters in Applied NanoBioScience · doi:10.33263/lianbs152.083
Schmid, C. D., Tuo, Y., Kürschner, S. W., Greco, A., Schüler, J., Hoffmann, J., Hardt, M. R., Trogisch, F. A., Weyer, V., Sticht, C., et al. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101905
Immunogenicity of High-resolution in situ structures of hantavirus glycoprotein tetramers
Erasmus, J. (2026) · ImmPort · doi:10.21430/m3aal4s28b
Metadata
- Authors
- Zhu, C., Kim, K., Wang, X., Bartolome, A., Salomao, M., Dongiovanni, P., Meroni, M., Graham, M. J., Yates, K. P., Diehl, A. M., Schwabe, R. F., Tabas, I., Valenti, L., Lavine, J. E., & Pajvani, U. B.
- Affiliations
- Columbia University (US)
- Department of Medicine, Columbia University, New York, NY 10032, USA.
- Mayo Clinic (US)
- University of Milan (IT)
- Ionis Pharmaceuticals (United States) (US)
- Johns Hopkins University (US)
- Duke Medical Center (US)
- Corresponding author
- Pajvani, Utpal B.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2018-11-21
- Volume
- 10
- Issue
- 468
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC6822168
- OpenAlex
- W2901663946
- Cited by
- 250
- References
- 78
- Citations by year
- 2026: 19 · 2025: 40 · 2024: 41 · 2023: 40 · 2022: 31 · 2021: 43 · 2020: 29 · 2019: 7
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK103818, DK105303)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- Notch signaling, hepatocytes, liver fibrosis, nonalcoholic steatohepatitis, antifibrotic therapy, diet-induced liver disease
- MeSH terms
- Animals, Choline, Diet, Female, Humans, Liver Cirrhosis, Male, Methionine, Mice, Inbred C57BL, Hepatocytes, Receptors, Notch, Osteopontin, Hepatic Stellate Cells, SOX9 Transcription Factor, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
